ATLS Musculoskeletal (MSK) Practice Test

Dipstick testing is often deemed unreliable for diagnosing crush syndrome primarily because it confuses myoglobin with hemoglobin. In cases of crush syndrome, muscle tissue damage can lead to the release of myoglobin into the bloodstream. However, standard dipstick tests are designed to detect hemoglobin from hemolysis rather than myoglobin specifically. While both myoglobin and hemoglobin can contribute to the presence of a positive test, the dipstick may give misleading results by falsely identifying myoglobin as hemoglobin, which can result in a misinterpretation of the patient's condition.

This confusion is particularly relevant because accurate recognition of myoglobinuria (the presence of myoglobin in urine) is crucial for diagnosing and managing crush syndrome effectively. Inaccurate results can lead to inappropriate treatment decisions, emphasizing the need for more specific testing methods, such as measuring serum creatine kinase levels or performing microscopic urine analysis to confirm myoglobin presence.